Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association
Why the study?
Differences in pathogenesis and pathophysiology between childhood and adult cardiomyopathies affect the utility of adult therapy strategies, necessitating dedicated guidance on pediatric treatment strategies.
Population
Children with cardiomyopathy
Design
American Heart Association scientific statement
Authors
Discussion
Loading...
Member takes
Implication
This AHA scientific statement provides a comprehensive framework for personalized, cause-specific treatment strategies for pediatric cardiomyopathies.
Structured PICO
P
Population
Children with cardiomyopathy, primarily dilated and hypertrophic phenotypes, as well as left ventricular noncompaction, restrictive, and arrhythmogenic cardiomyopathies.
I
Intervention
Personalized therapy based on specific cardiac pathophysiology, root cause identification (precision medicine), and clinical milieu.
This AHA scientific statement provides a comprehensive framework for personalized, cause-specific treatment strategies for pediatric cardiomyopathies.
Coverage & sources
Journal, society, and media accounts. Useful signal, not independent expert judgment.
Cite This Study
Bogle et al. (2023) studied this question.